CSBR Crosses Above Average Analyst Target
September 20, 2018 at 07:53 AM EDT
In recent trading, shares of Champions Oncology, Inc. (CSBR) have crossed above the average analyst 12-month target price of $12.33, changing hands for $13.98/share..